Label

- Eli Lilly and Company

Latest Eli Lilly and Company Patents:

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front, top, right perspective view of a label shown in an environment of use;

FIG. 2 is a rear view thereof;

FIG. 3 is a front view thereof;

FIG. 4 is a left side view thereof;

FIG. 5 is right side view thereof;

FIG. 6 is a top plan view thereof; and,

FIG. 7 is a bottom plan view thereof.

The autoinjector shown in even broken lines depicts environment that does not form part of the claimed design.

Claims

The ornamental design for a label, as shown and described.

Referenced Cited
U.S. Patent Documents
5924561 July 20, 1999 Baumgartner
D432245 October 17, 2000 Stevens et al.
D435662 December 26, 2000 Stevens et al.
D435663 December 26, 2000 Stevens et al.
D435664 December 26, 2000 Stevens et al.
D436182 January 9, 2001 Stevens et al.
D436183 January 9, 2001 Stevens et al.
D588200 March 10, 2009 Langan et al.
D593613 June 2, 2009 Langan et al.
D595361 June 30, 2009 Langan et al.
D597608 August 4, 2009 Langan et al.
D602534 October 20, 2009 Langan et al.
D605228 December 1, 2009 Langan et al.
D605229 December 1, 2009 Langan et al.
D607941 January 12, 2010 Langan et al.
D614703 April 27, 2010 Langan et al.
D621879 August 17, 2010 Langan et al.
D621880 August 17, 2010 Langan et al.
D624595 September 28, 2010 Langan et al.
D624596 September 28, 2010 Langan et al.
D633151 February 22, 2011 Langan et al.
D634367 March 15, 2011 Langan et al.
D634368 March 15, 2011 Langan et al.
D634369 March 15, 2011 Langan et al.
D639861 June 14, 2011 Langan et al.
D639862 June 14, 2011 Langan et al.
D639863 June 14, 2011 Langan et al.
D641421 July 12, 2011 Langan et al.
D641422 July 12, 2011 Langan et al.
D643468 August 16, 2011 Langan et al.
D643469 August 16, 2011 Langan et al.
D643470 August 16, 2011 Langan et al.
D643471 August 16, 2011 Langan et al.
D643472 August 16, 2011 Langan et al.
D645094 September 13, 2011 Langan et al.
D661742 June 12, 2012 Clark et al.
D677732 March 12, 2013 Clark et al.
8734394 May 27, 2014 Adams et al.
D739011 September 15, 2015 Morrison, Jr. et al.
D773650 December 6, 2016 Fourt et al.
9872961 January 23, 2018 Fourt et al.
10350362 July 16, 2019 Dennis, Jr. et al.
D860472 September 17, 2019 Blake et al.
D861796 October 1, 2019 Hahn
D898900 October 13, 2020 Atterbury et al.
D905788 December 22, 2020 Kumar et al.
11065386 July 20, 2021 Atterbury et al.
D926969 August 3, 2021 Dennisur
D942544 February 1, 2022 Banh et al.
D958328 July 19, 2022 Dennisur
D1065512 March 4, 2025 Boyaval
D1072050 April 22, 2025 Fernandez Marin
D1074811 May 13, 2025 Fernandez Marin
D1075920 May 2025 Fernandez Marin
12303672 May 2025 Kemp
D1084128 July 15, 2025 Hockmuller
Other references
  • “How to Use the Trulicity Pen for Type 2 Diabetes | Trulicity (dulaglutide),” www.trulicity.com/how-to-use. Accessed Jun. 10, 2022.
  • Linjawi, S., What Is Trulicity (Dulaglutide) and How Does It Work?, My Health Explained, accessed Jul. 14, 2023 at https://www.myhealthexplained.com/diabetes-information/diabetes-videos/trulicity-how-do-i-use-it-and-what-does-it-do, (published Sep. 28, 2021 as indicated by Wayback machine).
Patent History
Patent number: D1114067
Type: Grant
Filed: May 19, 2025
Date of Patent: Feb 17, 2026
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventors: Fernando Ludwig Fernandez Marin (Maplewood, NJ), Frank N. Hockmuller (Noblesville, IN), Yuchen Liu (Flushing, NY), Ross Stephen Merkel (Fishers, IN), Joseph Vito Primiani (Astoria, NY), J Geoffrey Swope (Indianapolis, IN)
Primary Examiner: Catherine Ho
Application Number: 30/004,329